International Sarcopenia Translational Research Conference 2023
Speaker (Newcastle Upon Tyne, UK)
In recent years there has been growing recognition of the clinical importance of sarcopenia but there is still a major need for more widespread diagnosis and the development of novel treatment options for this highly prevalent age-related condition. Translational research is key to these aims. Great strides are being made in our scientific understanding of sarcopenia and the challenge now is to translate these advances into better care and treatments for older people. Our CMO Dr. Silke Hüttner will provide a talk on drug development for sarcopenia.
BioJapan 2023
Exhibitor and speaker (Yokohama, Japan)
Asia's premier partnering event, focusing on providing new value by business partnering of industry, academia, and government from over the world. Ann Beliën, CEO, will present "Rejuvenate Biomed initiating sarcopenia phase 2 study for its lead candidate as identified through proprietary drug discovery platforms (Series C fundraising)".